MedPath

Survey on Convalescent Plasma (CVP) for COVID-19

Not Applicable
Registration Number
CTRI/2020/07/026331
Lead Sponsor
AIIMS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Not applicable

Exclusion Criteria

Anyone aged below 18 years.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To explore the knowledge, attitude, and practices of medical professionals regarding the convalescent plasma as a promising therapy for the current COVID-19 pandemic. <br/ ><br>2.To explore the knowledge, attitude of public in community regarding the convalescent plasma as a promising therapy for the current COVID-19 pandemic.Timepoint: 3 months
Secondary Outcome Measures
NameTimeMethod
1.To explore the knowledge-based difference between the public and healthcare workers regarding the CVP for COVID-19 <br/ ><br>2.To assess the difference in attitude of donor against non-donors regarding CVP donation. <br/ ><br>3.To explore the knowledge-based difference of healthcare workers of different cadres regarding the CVP donations for the current COVID-19 pandemic.Timepoint: 3 months
© Copyright 2025. All Rights Reserved by MedPath